These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 14470745)
1. [Therapeutic effects of R 1625 (Serenase) in small and medium doses in the psychiatric field]. MASCIOCCHI A; MARINO A; SFONDRINI E Rass Studi Psichiatr; 1961; 50():781-808. PubMed ID: 14470745 [No Abstract] [Full Text] [Related]
2. [Haloperidol (R 1625) in psychiatric therapy]. DELLA PIETRA V; FINA G Osp Psichiatr; 1960; 28():39-74. PubMed ID: 13885181 [No Abstract] [Full Text] [Related]
3. [First results of the treatment of 60 cases of mental disorders with a new neuroleptic agent, haloperidol (R 1625)]. ALLEVA PM Riv Sper Freniatr Med Leg Alien Ment; 1960 Mar; 84():248-60. PubMed ID: 13792796 [No Abstract] [Full Text] [Related]
4. [Clinical experiences with a new psychosedative: Ro 1-9569]. ESPINOSA J Rev Esp Otoneurooftalmol Neurocir; 1960; 19():14-9. PubMed ID: 13820811 [No Abstract] [Full Text] [Related]
5. [On the ambulatory use of "covatin" in some nervous diseases]. STEFANI G Gazz Med Ital; 1959 Dec; 118():557-9. PubMed ID: 13834000 [No Abstract] [Full Text] [Related]
7. A combination sedative in emotionally disturbed office patients. KOLODNY AL; FULLER HL Dis Nerv Syst; 1960 Apr; 21():220-5. PubMed ID: 14410752 [No Abstract] [Full Text] [Related]
8. The choice of drugs for disturbed psychiatric patients. COATES TF Va Med Mon (1918); 1953 Nov; 80(11):624-5. PubMed ID: 13102951 [No Abstract] [Full Text] [Related]
9. [Trial therapy with methylpentynol carbamate in ambulatory psychiatric treatment]. HELD R Sem Hop; 1956 Apr; 32(23):1326-33. PubMed ID: 13324245 [No Abstract] [Full Text] [Related]
10. A comparative study of six ataraxics in 1130 neuro-psychiatric cases. PENNINGTON VM Miss Doct; 1956 May; 33(12):336-9. PubMed ID: 13309155 [No Abstract] [Full Text] [Related]
11. Diethylammonium paraaminobenzoate in psychiatric practice. LANDRIANI F Gazz Med Ital; 1952 Oct; 111(10):269-72. PubMed ID: 13021413 [No Abstract] [Full Text] [Related]
12. On chemical tranquillizers. SARGANT W Br Med J; 1956 Apr; 1(4973):939-43. PubMed ID: 13304386 [No Abstract] [Full Text] [Related]
13. The use of sedative and stimulative drugs in emotional illness. BARTA FR Nebr State Med J; 1952 May; 37(5):144-8. PubMed ID: 14941116 [No Abstract] [Full Text] [Related]
14. [Lysergic acid monoethylamide, a new ergot derivatives with sedative effect in psychiatric medication]. SOLMS H Schweiz Arch Neurol Psychiatr; 1954; 73(1-2):440-4. PubMed ID: 13195594 [No Abstract] [Full Text] [Related]
15. The effect of R-1625 (Haloperidol) in mental syndromes: a multiblind study. AZIMA H; DUROST H; ARTHURS D Am J Psychiatry; 1960 Dec; 117():546-7. PubMed ID: 13685433 [No Abstract] [Full Text] [Related]
16. Report on a new drug, captodiamine: a preliminary investigation. CASTNER CW; NOBLE RC Dis Nerv Syst; 1959 Dec; 20():594-6. PubMed ID: 13808321 [No Abstract] [Full Text] [Related]
17. [Therapeutic trial with SCTZ--a new hypnotic--in psychotic diseases]. OSTERMAN E; BELLANDER-LOFVENBERG S; LASSENIUS B Nord Med; 1959 Aug; 62():1191-3. PubMed ID: 14429302 [No Abstract] [Full Text] [Related]
19. [Importance of R 1625 (Haloperidol) in the treatment of chronic hallucinatory psychoses]. JACOB E; MARIE C Ann Med Psychol (Paris); 1961 Dec; 119(2)():948-9. PubMed ID: 14450639 [No Abstract] [Full Text] [Related]
20. [Clinical experience with Haloperidol]. KRISTJANSEN P; HANSEN G Nord Med; 1961 Jun; 65():812-5. PubMed ID: 13754383 [No Abstract] [Full Text] [Related] [Next] [New Search]